Related Experiment Videos
Summary
A novel anti-cancer protein, cesalin, was isolated from Caesalpinia gilliesii seeds. Cesalin demonstrated significant inhibition of Walker 256 carcinosarcoma growth in rats, indicating potential as an anti-neoplastic agent.
Area of Science:
- Biochemistry
- Pharmacology
- Plant-derived compounds
Background:
- Cancer research seeks novel therapeutic agents.
- Plant endosperm is a source of bioactive compounds.
- Caesalpinia gilliesii seeds contain potential anti-neoplastic substances.
Purpose of the Study:
- To isolate and characterize an anti-neoplastic protein from Caesalpinia gilliesii seeds.
- To evaluate the anti-tumor activity of the isolated protein against Walker 256 carcinosarcoma.
Main Methods:
- Protein extraction from seed endosperm.
- Purification using dialysis, ammonium sulfate precipitation, and column chromatography.
- Characterization by gel electrophoresis and molecular weight determination.
- In vivo anti-tumor testing in rats.
Main Results:
- Isolation of a protein, cesalin, with anti-neoplastic properties.
- Cesalin exhibited significant inhibition (70-80%) of Walker 256 carcinosarcoma growth.
- Cesalin has a molecular weight of 110,000 daltons and consists of approximately 30,000 dalton subunits.
- A small amount of hexosan carbohydrate is associated with cesalin.
Conclusions:
- Cesalin is a promising anti-cancer agent derived from plant sources.
- Further research into cesalin's mechanism of action and therapeutic potential is warranted.
- Caesalpinia gilliesii seeds represent a valuable source for novel anti-tumor drug discovery.